Chargement en cours...

Delayed Treatment with a Novel Neurotrophic Compound Reduces Behavioral Deficits in Rabbit Ischemic Stroke

Acute ischemic stroke is a major risk for morbidity and mortality in our aging population. Currently only one drug, the thrombolytic tissue plasminogen activator, is approved by the FDA to treat stroke. Therefore, there is a need to develop novel drugs that promote neuronal survival following stroke...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lapchak, Paul A., Schubert, David R., Maher, Pamela A.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004475/
https://ncbi.nlm.nih.gov/pubmed/21054387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1471-4159.2010.07090.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!